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Probes Lead to False Discovery of
Autosomal Sex-Associated DNA
MethylationTo the Editor: The majority of the significant sex-associ-
ated DNA-methylation sites at autosomal CpG loci re-
ported by Numata et al.1 do not reflect a true biological
phenomenon. Rather, the conclusions in this paper reflect
a technical artifact created by the presence of cross-reactive
autosomal probes hybridizing to both autosomal and sex
chromosomes.
Numata et al.1 used the Illumina Infinium HumanMe-
thylation27K microarray to assess genome-wide DNA
methylation. This microarray uses 50 nt probes to target
27,578 CpG sites covering ~13,000 genes. So that one
can distinguish between the methylated and unmethy-
lated alleles, DNA is treated with sodium bisulfite for con-
verting unmethylated cytosines to uracil. Then, PCR
amplification converts uracil to thymidine. In contrast,
methylated cytosines remain cytosines. In this microarray,
two probes are designed for each CpG site—one is designed
for the methylated allele (cytosine), and the other is de-
signed for the unmethylated allele (thymidine).
On the Illumina Infinium HumanMethylation27K mi-
croarray, there is a subset of probes that target autosomal
loci but cross-react with genomic regions on the sex chro-
mosomes. Because one of the X chromosomes in females
is heavily methylated as a result of X inactivation,2 auto-
somal CpG loci targeted by probes that overlap these
heavily methylated loci create spurious signals and there-
fore appear more methylated in females than in males.On the other hand, autosomal probes cross-hybridizing to
unmethylated X chromosome loci that escape X inactiva-
tion show lower methylation in females than in males.
Likewise for theY chromosome, probes that cross-hybridize
also shift the DNA-methylation level of the originally tar-
geted autosomal CpG loci to produce a spurious increase
in the methylation signals in males compared to females.
We can identify cross-reactive probes on the 27K micro-
array as having highly identical matches to nontargeted
loci by first mapping probe sequences against the
in silico sodium-bisulfite-converted reference genome
(hg18) by using BLAT.3 In addition, the end nucleotide of
the probes and the nontargeted loci are required to be
the same for cross-hybridization to occur because array
signals are derived from single-base extension of fluores-
cently tagged nucleotides at one end of the probes that
correspond to the targeted CpGs. In Table 1, we have ap-
pended the potential cross-hybridizing targets of probes
corresponding to the top ten autosomal genes described
by Numata et al.1 as having the most significant sex differ-
ences. Using the same microarray platform, Liu et al. and
Adkins et al.4–6 also reported the same overlapping set of
autosomal sex-associated DNA-methylation sites, which
we have found to be the result of technical artifact.3 The
claim by Numata et al.1 that 5% of autosomal loci (or
1,333 CpGs) have significant differential methylation asso-
ciated with sex is likely to be an overestimate because of
the presence of autosomal probes cross-hybridizing to
the sex chromosomes. The full list of CpG sites proposed
to have significant sex differences was not published, so
they could not be evaluated. Of course, this does not
exclude the possibility that there are indeed true auto-
somal sex-associated sites of DNA methylation in humans
because two of the top ten autosomal sex-associated
CpG sites reported by Numata et al.1 are not targeted by5, 2012
Table 1. Cross-reactive Autosomal Probes Lead to False Discovery of Sex-Associated DNA Methylation
From Numata et al.1 Cross-hybridizing Targets
CpG Locus Chromosome Gene p Value (log) Difference Chromosome Length (bp) Mismatch (bp)
cg15915418 9 TLE1 64.9 female > male X 50 0
cg07711515 9 BAG1 60.8 female < male X 50 0
cg27063525 6 C6orf68 46.7 female > male X 50 0
cg11673803 10 GLUD1 44.3 female > male X 50 0
cg21243096 1 POUF3F1 44.2 female > male X 50 4
cg04455759 11 SDHD 28.4 female < male X 45 2
cg08284151 12 DPPA3 20.1 female > male X 50 2
cg05924191 15 FLI20582 17.8 female > male X 50 2
cg23758485 16 SMPD3 17.4 female > male none none none
cg07494248 2 HSPD1 16.4 female > male none none none
The first five columns are from Table 1 of Numata et al.1 Note that the Illumina Infinium 27K microarray probes are 50 bases long, and, therefore, high-sequence
identity of the probe sequences to unintended targets would suggest cross-reactivity. For detailed methods of identifying cross-hybridizing targets, please refer to
our previous paper.3cross-reactive probes. Notably, several other studies have
observed true autosomal sex-associated DNA methylation
by using targeted molecular approaches.7,8
The recognition of falsely discovered autosomal sex-
associated DNA-methylation sites in our laboratory led us
to perform a series of bioinformatic analyses to identify
other potential cross-hybridizing targets. We found 6%–
10% of the 27,578 probes in the Illumina Infinium 27Kmi-
croarray to be cross-reactive and to thereby potentially
generate false positives and reduce the power of down-
stream analyses.3 For example, of the top 100 most signif-
icant CpG loci reported by Numata et al.1 to be associated
with developmental stages, age, expression, cis-mQTLs
(methylation quantitative trait loci) or trans-mQTLs, we
found a substantial overlap between cis- and trans-mQTLs
and CpG loci targeted by cross-reactive probes on the basisTable 2. Proportion of Significant CpGs Targeted by Cross-reactive Pr
From Numata et al.1
Top 100 CpGs showing significant methylation changes during the fetal perio
Top 100 CpGs showing significant methylation changes during childhood (0–
Top 100 CpGs showing significant methylation changes over the age of 10 ye
48 CpGs showing significant age-related changes in cancer-related genes
Top 100 negative correlations between gene expression and CpG methylation
Top 100 significant cis-mQTLs
Top 100 significant trans-mQTLs
Top 100 mQTLs in African American subjects
Top 100 mQTLs in subjects of European descenta
From Chen et al.3
All 27,578 CpGs in the 27K microarray
The top 100 significant CpGs are taken from the supplementary tables of Numata e
probes3 and polymorphic CpGs (see Web Resources).The following abbreviation
aThese individuals were mentioned to be Caucasian in Numata et al.1
The Americof our previously published list of cross-reactive probes3
(Table 2). We also observed significantly higher propor-
tions of cross-reactive probes in cis- and trans-mQTLs
(23% and 28%, respectively)1 than in the entire array
(6%–10%).3 This raises the possibility that the cross-
hybridizing targets might overlap underlying SNPs and
might thereby create spurious signals for which intensities
depend on SNP genotypes. The fact that cross-reactive
probes have multiple targets, i.e., an increased chance of
hybridizing to a SNP variant rather than a single unique
target, could explain the observed enrichments.
Another potential source of error in generating data
from the 27K microarray arises from probes targeting poly-
morphic CpGs (i.e., SNPs at either cytosine or guanine).3 A
total of 907 (3%) CpG sites overlapping SNPs (dbSNP build
132) are targeted by this microarray (see Web Resources).obes or SNPs in Numata et al. Study
Proportion of CpGs
Targeted by
Cross-reactive Probes
Polymorphic
CpGs (SNPs)
d 5% 4%
10 years) 3% 3%
ars 10% 0%
6% 4%
3% 4%
23% 29%
28% 14%
9% 9%
11% 8%
6%–10% 3%
t al.1 Their probe IDs were cross-matched to the published lists of cross-reactive
is used: mQTLs, methylation quantitative trait loci.
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Notably, a large proportion (29%) of the top 100 most
significant cis-mQTLs reported by Numata et al.1 are linked
to probes targeting loci that are polymorphic CpGs (i.e.,
SNPs overlapping CpG sites) (Table 2). In these cases, the
methylation changes are likely to be a reflection of the
underlying polymorphism. That is, the methylation level
reflects alternate haplotypes of in-cis-associated SNPs
so that non-CG variants of polymorphic CpGs would be
detected as unmethylated loci.3 Further, the proportion
of polymorphic CpGs is 2–43 higher in the top 100 most
significant trans-mQTLs (14%), mQTLs in African
Americans (9%), and mQTLs in individuals of European
descent (mentioned as Caucasian in Numata et al.1) (8%)
than in the entire array (3%) (Table 2). This further demon-
strates the effect of polymorphisms at CpG loci on
the evaluation of DNA methylation, suggesting that any
quantitative association (e.g., between methylation and
gene expression) involving these CpG loci could be greatly
perturbed by the underlying genotypes of the population
studied.
The existence of cross-reactive probes and polymorphic
CpGs in the Illumina Infinium 27K microarray reflects
the human genome’s natural diversity, which results
from homologous and repetitive sequences and SNPs.
Therefore, investigators should exercise caution when
significant associations are found at CpG sites that are
either polymorphic or targeted by cross-reactive probes.
Biological interpretation requires validation of the detected
methylation by other approaches such as sodium-bisulfite
pyrosequencing. That Numata et al.1 and three other
studies4–6 reported parallel findings previously shown to
be the result of cross-reactive probes3 is concerning. False
discovery has the potential to be used for inappropriately
generating hypotheses or inferring biological significance.
Considering that the Illumina platform is one of the most
widely used DNA-methylation microarrays, we hope this
letter will serve as a cautionary note for researchers who
use Illumina Infinium DNA-methylation microarrays.
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Web Resources
The URL for data presented herein is as follows:
List of cross-reactive probes and polymorphic CpGs in the
Illumina 27K microarray, http://www.sickkids.ca/Research/
Weksberg-Lab/Publications/index.html
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